• AstraZeneca is acquiring US biotech company Alexion for $39 billion in cash and shares, for a value of $175 per share, compared to $120.98 at Friday's close.
  • California will join the lawsuit against Google.
  • FDA approves Pfizer and BioNTech's vaccine for emergency use.
  • Electronic Arts outbids Take-Two's bid for Codemasters.
  • The boss of Fiat, Mike Manley, favorite to take over the direction of Ferrari, according to Il Messaggero.
  • Oracle will leave Silicon Valley to settle in Texas.
  • Elliott invites itself to the capital of Public Storage.
  • In the United States, Huntington Bancshares and TCF Financial will merge.
  • Vista Equity Partners wants to buy Pluralsight for USD 20.26 per share.
  • EQT proposes to buy Recipharm for SEK 220 per share in cash.
  • Novartis fails with ruxolitinib against Covid-19.
  • State Street could separate from its asset management branch, according to Bloomberg.
  • Germany is going to take 25% of the defense equipment manufacturer Hensoldt for €464 M, to prevent this strategic player and former Airbus subsidiary from falling into foreign hands.
  • Roblox and Affirm are postponing their Nasdaq entries to 2021 because of the confusion created by the surge in Airbnb and DoorDash shares during their own IPOs last week, according to the Wall Street Journal.
  • Proximus buys out Mobile Vikings.
  • Sensirion raises its 2020 targets.
  • ABB Ltd. will repay $100 million to the public group Eskom in South Africa.